Rohto Pharmaceutical Co.,Ltd. (RPHCF)
Rohto Pharmaceutical Co.,Ltd. operates in the Household & Personal Products industry of the Consumer Defensive sector, headquartered in Osaka, OS, JP. The stock last traded at $15.00, up 0.00% on the session, giving a market capitalisation of $3.39B. On trailing twelve-month figures it carries a trailing P/E of 19.44, a net margin of 9.4%. Its beta of -0.44 implies it has historically moved less than the broad market.
Rohto Pharmaceutical Co.,Ltd. operates as a global enterprise, specializing in the manufacturing and distribution of pharmaceuticals, cosmetics, and health-enhancing functional foods. Their extensive product line encompasses a variety of eye care solutions, including eye drops, contact lens maintenance products, and eye washes. They also offer a comprehensive range of facial care items such as cleansers, lotions, and creams. Beyond these, Rohto's offerings extend to topical skin treatments, internal medications (comprising digestive and herbal remedies), and oral health products like gastrointestinal aids and nutritional supplements. The company is also a provider of over-the-counter pharmaceuticals and operates dedicated beauty counters that furnish health and wellness services. Established in 1899, the company was initially known as Yamada Pharmaceutical before officially adopting the name Rohto Pharmaceutical Co.,Ltd. in September 1949. Its corporate headquarters are situated in Osaka, Japan.
Rohto Pharmaceutical Co.,Ltd. is most often compared with the following Consumer Defensive names: